Applying the syndemic framework to cancer research for effective cancer control in LMICs
Applying the syndemic framework to cancer research for effective cancer control in LMICs
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Cancer Survivorship
Why tumour markers are not recommended as screening tests
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort
Choosing wisely in complementary treatment for cancer in the Philippines
Indications for the appropriate use of a PET-CT scan for common cancers
A multidisciplinary team approach to cancer care in the Philippines
Choosing the right serum and molecular biomarkers in the Philippines
Latest treatments in oesophageal cancer
Tumour markers and their role in cancer treatment